SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...

FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

FDA announced the launch of Elsa, a generative artificial intelligence (AI) tool designed to help employees from scientific ...

Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...

Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...

Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict ...

The FDA is moving quickly to bring artificial intelligence (AI) into the heart of its regulatory review process. On May 8, ...